Eversept Partners, LP Surmodics Inc Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$51.29 - $59.15 $2.46 Million - $2.83 Million	-47,906 Closed	0 $0
Q1 2021 Nov 08, 2023	BUY	$42.18 - $56.07 $278,683 - $370,454	6,607 Added 16.0%	47,906 $2.69 Million
Q1 2021 May 13, 2021	BUY	$42.18 - $56.07 $278,683 - $370,454	6,607 Added 16.0%	47,906 $2.69 Million
Q4 2020 Nov 08, 2023	BUY	$35.18 - $43.52 $1.45 Million - $1.8 Million	41,299 New	41,299 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$35.18 - $43.52 $1.45 Million - $1.8 Million	41,299 New	41,299 $1.8 Million

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.